Cellectar Biosciences Reports First Quarter 2015 Financial Results and Provides Update on Clinical Programs

Go back to Cellectar Biosciences Reports First Quarter 2015 Financial Results and Provides Update on Clinical Programs

Cellectar Biosciences (CLRB) Reports Q1 Loss of $0.30/Share

May 21, 2015 4:17 PM EDT

Cellectar Biosciences (NASDAQ: CLRB) reported Q1 EPS of ($0.30), versus ($1.03) reported last year.

For earnings history and earnings-related data on Cellectar Biosciences (CLRB) click here.

... More